FdaApplication
NDA 208246
Identifiers
- fda_app_no: NDA208246
Properties
| Property | Value |
|---|---|
| applicant_name | PFIZER INC |
| application_type | NDA |
| approval_date | 2016-02-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XELJANZ XR | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| XELJANZ XR | TOFACITINIB CITRATE | EQ 22MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products